1230 related articles for article (PubMed ID: 17599306)
1. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
[TBL] [Abstract][Full Text] [Related]
4. Past, present, and future therapies for Clostridium difficile-associated disease.
Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies for C. difficile associated diarrhea.
Stepan C; Surawicz CM
Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and appropriateness of empiric metronidazole for Clostridium difficile-associated diarrhea.
Vasa CV; Glatt AE
Am J Gastroenterol; 2003 Feb; 98(2):354-8. PubMed ID: 12591054
[TBL] [Abstract][Full Text] [Related]
7. Update on Clostridium difficile-induced colitis, Part 2.
Reinke CM; Messick CR
Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
Pekova L; Shomov G; Mladenova I; Pellicano R
Minerva Gastroenterol Dietol; 2007 Dec; 53(4):383-6. PubMed ID: 18043555
[TBL] [Abstract][Full Text] [Related]
9. Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease.
Sethi AK; Al-Nassir WN; Nerandzic MM; Donskey CJ
Infect Control Hosp Epidemiol; 2009 Jan; 30(1):13-7. PubMed ID: 19046063
[TBL] [Abstract][Full Text] [Related]
10. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea.
Wullt M; Odenholt I
J Antimicrob Chemother; 2004 Jul; 54(1):211-6. PubMed ID: 15163651
[TBL] [Abstract][Full Text] [Related]
11. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
McFarland LV; Elmer GW; Surawicz CM
Am J Gastroenterol; 2002 Jul; 97(7):1769-75. PubMed ID: 12135033
[TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea.
Lagrotteria D; Holmes S; Smieja M; Smaill F; Lee C
Clin Infect Dis; 2006 Sep; 43(5):547-52. PubMed ID: 16886144
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
[TBL] [Abstract][Full Text] [Related]
14. The changing face of Clostridium difficile: what treatment options remain?
Shen EP; Surawicz CM
Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
Pepin J
Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
18. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
Le F; Arora V; Shah DN; Salazar M; Palmer HR; Garey KW
Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
[TBL] [Abstract][Full Text] [Related]
19. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
Pépin J; Routhier S; Gagnon S; Brazeau I
Clin Infect Dis; 2006 Mar; 42(6):758-64. PubMed ID: 16477549
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.
Juang P; Skledar SJ; Zgheib NK; Paterson DL; Vergis EN; Shannon WD; Ansani NT; Branch RA
Am J Infect Control; 2007 Mar; 35(2):131-7. PubMed ID: 17327194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
